Definitely some blunders along the way, the R/S an

Definitely some blunders along the way, the R/S announcement and cancellation I complained about at the time and a couple times since, amateur hour, the salary raise early this year announced with a CC (I don't see how he got 53% to approve), the TO this summer without pushing news, I don't understand. The over-promising, I don't understand. NP said at the shareholder meeting 6 weeks, yesterday he said end of year. People upset from that time change, which has probably sparked these discussions. Does it mean anything? I'm not sure, he gave milestone payments again. Could be overcautious, maybe they are doing more DD, maybe they are waiting on mono news or BLA news... we will see. But that inconsistent language is very frustrating for people, yes. I wouldn't doubt if we hear the 5 weeks time frame now again at some point soon. Just like the 35k, 100k cost per year.

Even with that, I guess having trading hundreds, maybe thousands lost count, of otc stocks, almost all with slimy CEOs, I'd rather stick with this one at this point.

NWBO is the most talked about biotech on ihub, people are all excited. Well, it is 25c today, 4 years ago it hit $12 on nasdaq. I guess it lost most shareholders along the way There can be a big step down from where we are at CEO and what other otc companies have, even with the blunders.